Clearline Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-201,024
Closed -$13.4M 126
2022
Q3
$13.4M Sell
201,024
-93,555
-32% -$5.93M 1.6% 19
2022
Q2
$15.4M Sell
294,579
-79,748
-21% -$4.53M 1.99% 18
2022
Q1
$21.2M Sell
374,327
-25,885
-6% -$1.39M 2.44% 9
2021
Q4
$20.6M Buy
400,212
+200,980
+101% +$9.86M 2.27% 7
2021
Q3
$9.85M Buy
+199,232
New +$10.8M 0.93% 36

Other funds holding CAH

Clearline Capital's CAH Position: Q4 2022 in Review

Clearline Capital sold out of Cardinal Health (CAH) in Q4 2022, closing a stake of 201,024 shares — an estimated $13.4M sold.

Clearline Capital first reported a position in CAH in Q3 2021 and held it in 5 quarters. The position peaked at $21.2M in Q1 2022. 929 funds tracked by Wall St. Rank hold CAH as of Q4 2022.

  • Clearline Capital reported no remaining Cardinal Health position as of Q4 2022 after selling out during the quarter.
  • Clearline Capital sold 201,024 Cardinal Health shares in Q4 2022, an estimated $13.4M.
  • Clearline Capital first reported a position in Cardinal Health in Q3 2021 and held it in 5 quarters.
  • Clearline Capital's Cardinal Health position peaked at $21.2M in Q1 2022.
  • 929 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.

Based on Clearline Capital's 13F filing for Q4 2022, filed 14 Feb 2023.